Graybug Vision (GRAY) Competitors $1.53 +0.01 (+0.66%) As of 04/23/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock GRAY vs. FLGC, BLRX, SNSE, PRTG, BTAI, ERNA, NEUP, HOOK, TRAW, and CSCIShould you be buying Graybug Vision stock or one of its competitors? The main competitors of Graybug Vision include Flora Growth (FLGC), BioLineRx (BLRX), Sensei Biotherapeutics (SNSE), Portage Biotech (PRTG), BioXcel Therapeutics (BTAI), Eterna Therapeutics (ERNA), Neuphoria Therapeutics Inc. - Common Stock (NEUP), Hookipa Pharma (HOOK), Traws Pharma (TRAW), and COSCIENS Biopharma (CSCI). These companies are all part of the "pharmaceutical preparations" industry. Graybug Vision vs. Flora Growth BioLineRx Sensei Biotherapeutics Portage Biotech BioXcel Therapeutics Eterna Therapeutics Neuphoria Therapeutics Inc. - Common Stock Hookipa Pharma Traws Pharma COSCIENS Biopharma Flora Growth (NASDAQ:FLGC) and Graybug Vision (NASDAQ:GRAY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk, institutional ownership and community ranking. Which has more volatility & risk, FLGC or GRAY? Flora Growth has a beta of 2.01, suggesting that its share price is 101% more volatile than the S&P 500. Comparatively, Graybug Vision has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Does the MarketBeat Community believe in FLGC or GRAY? Graybug Vision received 1 more outperform votes than Flora Growth when rated by MarketBeat users. However, 60.00% of users gave Flora Growth an outperform vote while only 50.00% of users gave Graybug Vision an outperform vote. CompanyUnderperformOutperformFlora GrowthOutperform Votes1560.00% Underperform Votes1040.00% Graybug VisionOutperform Votes1650.00% Underperform Votes1650.00% Is FLGC or GRAY more profitable? Graybug Vision has a net margin of 0.00% compared to Flora Growth's net margin of -30.99%. Graybug Vision's return on equity of -77.61% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets Flora Growth-30.99% -268.17% -57.51% Graybug Vision N/A -77.61%-71.34% Does the media refer more to FLGC or GRAY? In the previous week, Flora Growth and Flora Growth both had 1 articles in the media. Graybug Vision's average media sentiment score of 1.10 beat Flora Growth's score of 0.00 indicating that Graybug Vision is being referred to more favorably in the news media. Company Overall Sentiment Flora Growth Neutral Graybug Vision Positive Do analysts rate FLGC or GRAY? Flora Growth presently has a consensus price target of $5.00, indicating a potential upside of 762.07%. Given Flora Growth's stronger consensus rating and higher possible upside, analysts clearly believe Flora Growth is more favorable than Graybug Vision.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Flora Growth 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Graybug Vision 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings & valuation, FLGC or GRAY? Graybug Vision has lower revenue, but higher earnings than Flora Growth. Flora Growth is trading at a lower price-to-earnings ratio than Graybug Vision, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFlora Growth$59.51M0.19-$57.04M-$1.32-0.44Graybug VisionN/AN/A-$35.60M-$24.23-0.06 Do institutionals and insiders believe in FLGC or GRAY? 36.0% of Flora Growth shares are owned by institutional investors. Comparatively, 49.9% of Graybug Vision shares are owned by institutional investors. 13.0% of Flora Growth shares are owned by insiders. Comparatively, 7.9% of Graybug Vision shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. SummaryFlora Growth beats Graybug Vision on 10 of the 16 factors compared between the two stocks. Get Graybug Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for GRAY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRAY vs. The Competition Export to ExcelMetricGraybug VisionPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.40M$6.68B$5.44B$7.80BDividend YieldN/A3.17%5.43%4.31%P/E Ratio-0.887.1422.1418.39Price / SalesN/A238.89389.70101.29Price / CashN/A65.6738.2034.62Price / Book0.926.266.664.18Net Income-$35.60M$142.48M$3.21B$247.71M7 Day Performance-1.29%7.91%5.83%6.45%1 Month Performance-23.88%-6.03%-4.32%-3.14%1 Year Performance-72.13%-0.96%17.83%5.40% Graybug Vision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRAYGraybug VisionN/A$1.53+0.7%N/A-66.7%$2.40MN/A-0.8827News CoveragePositive NewsGap UpHigh Trading VolumeFLGCFlora Growth1.9113 of 5 stars$0.50-7.1%$5.00+900.0%-62.6%$9.72M$59.51M-0.38280Gap UpBLRXBioLineRx1.2765 of 5 stars$2.90+0.7%$26.00+796.6%-87.8%$9.65M$28.94M-0.3340Gap UpSNSESensei Biotherapeutics3.8182 of 5 stars$0.38-5.8%$4.25+1,012.6%-61.8%$9.63MN/A-0.3240PRTGPortage Biotech0.2176 of 5 stars$9.09+15.9%N/A+85.3%$9.54MN/A-0.226Negative NewsBTAIBioXcel Therapeutics3.5305 of 5 stars$1.71-1.7%$42.60+2,391.2%-95.7%$9.38M$2.27M-0.0590Gap DownERNAEterna Therapeutics0.908 of 5 stars$0.18-3.4%N/A-88.2%$9.34M$582,000.00-0.0210NEUPNeuphoria Therapeutics Inc. - Common Stock1.1694 of 5 stars$5.20+1.2%$21.00+303.8%N/A$9.14M$662,715.000.00N/AHOOKHookipa Pharma2.2104 of 5 stars$0.75-3.0%$23.00+2,966.7%-90.1%$9.04M$43.95M-0.2056TRAWTraws Pharma0.3416 of 5 stars$1.76-11.1%N/AN/A$8.93M$226,000.00-0.0117CSCICOSCIENS BiopharmaN/A$3.05+7.8%N/AN/A$8.89M$9.59M-0.2620Gap Up Related Companies and Tools Related Companies FLGC Competitors BLRX Competitors SNSE Competitors PRTG Competitors BTAI Competitors ERNA Competitors NEUP Competitors HOOK Competitors TRAW Competitors CSCI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GRAY) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graybug Vision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Graybug Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GRAY Stock Free GRAY Stock Alerts